Company Quick10K Filing
Emerging CTA Portfolio
10-Q 2020-06-30 Filed 2020-08-11
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-26
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-26
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-28
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-03-28
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-30
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-28
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-27
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-07-01 Enter Agreement, Exhibits
8-K 2020-06-04
8-K 2020-03-31
8-K 2019-08-23
8-K 2019-06-30
8-K 2019-03-31
8-K 2019-03-06
8-K 2018-10-31
8-K 2018-10-15
8-K 2018-09-28
8-K 2018-09-15
8-K 2018-04-30
8-K 2018-03-01
8-K 2018-01-01

Emerging CTA Portfolio Financials

CTA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Madison Ventures (MDSV) -0.3 0 748 0 0 -327 -290 97
Vericity (VERY) 0% 5.7 -1% 806,697 498,016 70,671 0 -11,136 -11,400 -64,552
Anvi Global Holdings (ANVI) 0.3 -162% 139 1,059 0 0 -225 -225 -70
Cardinal Ethanol (CARD) 0% -3.1 -5% 137,552 25,273 260,669 36 -6,599 5,002 -15,308
Monitronics International (MTII) 54% -3.7 -33% 1,457,388 1,088,795 428,422 229,710 -473,690 -261,950 965,325
ECCO Auto World (ECCO) 100% 0.9 -42% 43 12 10 10 -18 -18 -16
Protective Life (PL) 0% -0.5 0% 119,751,045 110,460,110 5,735,562 0 383,675 544,873 -293,299
Everflow Eastern Partners (EEPL) 51% -4.2 6% 41,678 22,380 6,257 3,207 2,357 2,800 -11,649
Reva Medical (RVA) -33% -0.3 154% 10,626 83,896 265 -88 16,394 23,305 -7,094
Heyu Biological Technology (HEYU) 44% 1.3 -33% 1,079 1,699 57 25 -357 -357 -452
Fellazo (FLLC) 14.7 -0% 280 267 0 0 -0 -0 -3
Medixall Group (MDXL) 0% 0.0 -381% 559 362 2 0 -2,130 -2,130 -51
Ultimate Products (ULPC) 0.0 -1,320% 1 93 0 0 -10 -10 -0
Bankguam (BKGMF) -10.1 1% 1,951,731 1,790,610 0 0 12,309 18,839 -189,809
Morgan Stanley Smith Barney Spectrum Select (DWSF) -1.3 14% 32,102 876 0 0 4,606 4,606 -6,133
Trine Acquisition (TRNE) -0.2 1% 304,312 10,707 0 0 2,053 2,599 -588
Vaparia (VAPA) 0.1 -34% 220 832 0 0 -75 -75 -7
Peptide Technologies (PEPT) 0.0 -22% 251 672 0 0 -56 -57 -1
Scientific Energy (SCGY) 0.2 -253% 146 1,980 0 0 -369 -366 -86
Digital Brand Media & Marketing (DBMM) 10% -1.5 -567% 111 4,347 329 32 -627 -537 820

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash52,42852,98348,19344,37249,83255,04362,98915,98521,58922,24024,96619,08226,72621,22625,78725,21614,92618,15015,655110014,1673,3322,5022,3821,4532,4302,7572,4422,9283,705
Accounts Receivable
Inventory
PP&E
Assets207,366214,520207,893215,555212,011209,274197,608187,153188,829173,358170,253148,928131,275119,439119,213116,652103,958104,45097,47192,20483,139371,350396,84761,87756,23150,47844,27141,42239,77239,27337,34842,95741,82524,707
Accounts Payable
Long-Term Debt
Liabilities9,0135,8382,9414,1854,9474,7359,4565,0674,1267,8188,13111,6303,5235,3384,5854,6532,8982,5243,1423,1214,5782,9765,3481,3162,7771,79118,0661,5131,5373,2462,7775,31241,825746
Stockholders' Equity198,353208,682204,952211,369207,064204,539188,152182,086184,703165,540162,122137,298127,752114,102114,628111,999101,061101,92594,32989,08478,561370,587391,49960,56153,45448,68741,74340,30639,58537,43335,17742,31225,01923,960
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A37834131536137431021818622718147159383356317295
Tax
Net Income8812,938-11,447-6,742-7,3871,884-1,5981,3395,581-13,6665,423-14,5072,0429957,9322,171-4,79728,611-3,2984,690-8872,330-1,5834,7411,705-1,3671,3723,5162,385-5903,2803,312161
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating
Cash Investing
Cash Financing